CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2012-09-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1113960109PMID 23012401PMCID PMC3529071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD24 is an effector of HIF-1-driven primary tumor growth and metastasis.

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Contractile Forces Contribute to Increased Glycosylphosphatidylinositol-anchored Receptor CD24-facilitated Cancer Cell Invasion*

  2011cited by this paper
• Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study

  2011cited by this paper
• Role of androgen receptor and associated lysine‐demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer

  2011cited by this paper
• Immunohistochemical biomarkers for bladder cancer prognosis

  2011cited by this paper
• CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.

  2011influential reference
• Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens

  2011cited by this paper
• Association between smoking and risk of bladder cancer among men and women.

  2011cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• The effect of smoking on the male excess of bladder cancer: A meta‐analysis and geographical analyses

  2009cited by this paper
• CD24 overexpression in cancer development and progression: a meta-analysis.

  2009cited by this paper
• The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy

  2008cited by this paper
• Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.

  2008influential reference
• Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.

  2008cited by this paper
• Molecular credentialing of rodent bladder carcinogenesis models.

  2008cited by this paper
• Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA.

  2008cited by this paper
• Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.

  2008cited by this paper
• Metastasis: a therapeutic target for cancer

  2008cited by this paper
• A Dinucleotide Deletion in CD24 Confers Protection against Autoimmune Diseases

  2007cited by this paper
• Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up

  2007cited by this paper
• Promotion of bladder cancer development and progression by androgen receptor signals.

  2007cited by this paper
• Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.

  2006cited by this paper
• CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.

  2006cited by this paper
• Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer

  2006cited by this paper
• Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.

  2006cited by this paper
• The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.

  2006influential reference
• Urothelial tumorigenesis: a tale of divergent pathways

  2005cited by this paper
• CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis.

  2005cited by this paper
• The role of CD24 in various human epithelial neoplasias.

  2005cited by this paper
• Bicalutamide (‘Casodex’) 150 mg in addition to standard care in patients with nonmetastatic prostate cancer: updated results from a randomised double-blind phase III study (median follow-up 5.1 y) in the early prostate cancer programme

  2005cited by this paper
• CD24 Expression on T Cells Is Required for Optimal T Cell Proliferation in Lymphopenic Host

  2004cited by this paper
• Gender, racial and age differences in bladder cancer incidence and mortality.

  2004influential reference
• Gene profiling and promoter reporter assays: Novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action

  2003cited by this paper
• Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule

  2003cited by this paper
• Quality of life aspects of bladder cancer: A review of the literature

  2003cited by this paper
• Categorical Data Analysis

  2003cited by this paper
• The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells.

  2000cited by this paper
• CD24 promotes invasion of glioma cells in vivo.

  1999cited by this paper
• Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice.

  1997cited by this paper
• Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines.

  1997cited by this paper
• B-cell maturation in chimaeric mice deficient for the heat stable antigen (HSA/mouse CD24)

  1995cited by this paper
• CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor.

  1991cited by this paper
• Unexplained excess risk of bladder cancer in men.

  1990cited by this paper
• Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.

  1986cited by this paper
• Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

  1985cited by this paper
• Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response.

  1972influential reference
• Differential Patterns of Vasculature to Liver Tumours

  1970cited by this paper
• Selektive Erzeugung von Blasenkrebs an Ratten durch Dibutyl- und N-Butyl-N-butanol(4)-nitrosamin

  1964cited by this paper
• [SELECTIVE INDUCTION OF BLADDER CANCER IN RATS BY DIBUTYL- AND N-BUTYL-N-BUTANOL(4)-NITROSAMINE].

  1964cited by this paper

• Silencing CD24 Inhibits Proliferation, Migration, and Chemoresistance in Triple-Negative Breast Cancer Cells.

  2026cites this paper
• RCC2 and CD24 cooperate to modulate prostate cancer progression through vimentin ubiquitination and β-catenin activation

  2025cites this paper
• Exploring the Impact of 5-Alpha Reductase Inhibitors on Bladder Cancer: Insights from a Large-Scale Prospective Cohort Study

  2025cites this paper
• Testosterone and Androgen Receptor in Cancers with Significant Sex Dimorphism in Incidence Rates and Survival

  2025cites this paper
• Decoding CD24: Roles of chemoradiotherapy resistance and potential as therapeutic targets

  2025cites this paper
• Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab

  2025cites this paper
• Le cancer de la vessie chez la femme – le biais du sexe

  2025cites this paper
• Sex differences in bladder cancer: understanding biological and clinical implications

  2025cites this paper
• Recent advances in understanding the role of sex hormone receptors in urothelial cancer

  2025influential citation
• Effects of androgen suppression therapy on the incidence and prognosis of bladder cancer: An updated systematic review and meta-analysis.

  2024cites this paper
• Preclinical models of bladder cancer: BBN and beyond

  2024cites this paper
• Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review

  2024cites this paper
• Roles of Androgen Receptor Signaling in Urothelial Carcinoma

  2024cites this paper
• Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions

  2024cites this paper
• CD24 targeting with NK‐CAR immunotherapy in testis, prostate, renal and (luminal‐type) bladder cancer and identification of direct CD24 interaction partners

  2023cites this paper
• Association of 5α-Reductase Inhibitor Prescription With Bladder Cancer Progression in Males in South Korea

  2023cites this paper
• The androgen receptor in bladder cancer

  2023cites this paper
• Emerging phagocytosis checkpoints in cancer immunotherapy

  2023cites this paper
• Cytoplasmic Androgen Receptor, CD24 Expression and Smoking Intensity to Urothelial Carcinoma of the Bladder Invasiveness: A Cross-Sectional Study

  2023cites this paper
• Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions

  2023cites this paper
• Single-cell profiling of murine bladder cancer identifies sex-specific transcriptional signatures with prognostic relevance

  2023cites this paper
• Prognostic Implications of CD24, SOX2, and Nanog Expression in Invasive Urothelial Carcinoma

  2023cites this paper
• Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities

  2022cites this paper
• CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma

  2022cites this paper
• CD24: A Marker for an Extended Expansion Potential of Urothelial Cancer Cell Organoids In Vitro?

  2022cites this paper
• Sex-biased adaptive immune regulation in cancer development and therapy

  2022cites this paper
• Bladder Cancer‐Derived Small Extracellular Vesicles Promote Tumor Angiogenesis by Inducing HBP‐Related Metabolic Reprogramming and SerRS O‐GlcNAcylation in Endothelial Cells

  2022cites this paper
• Mechanism of Sex Differences in Bladder Cancer: Evident and Elusive Sex-biasing Factors

  2022cites this paper
• Possible role of 5-alpha reductase inhibitors in non-invasive bladder urothelial neoplasm: multicenter study

  2022cites this paper
• Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy

  2021cites this paper
• Gender Differences in Urothelial Bladder Cancer: Effects of Natural Killer Lymphocyte Immunity

  2021cites this paper
• Gender Disparities in Bladder Cancer

  2021cites this paper
• Androgen Receptor Regulates CD44 Expression in Bladder Cancer

  2021cites this paper
• DNA Promoter Methylation and ERG regulate the expression of CD24 in prostate cancer.

  2021cites this paper
• High Expression Level of PPARγ in CD24 Knockout Mice and Gender-Specific Metabolic Changes: A Model of Insulin-Sensitive Obesity

  2021cites this paper
• Bladder Cancer

  2021cites this paper
• Advances in bladder cancer biology and therapy

  2020cites this paper
• Targeted Delivery of Therapeutics to Urological Cancer Stem Cells.

  2020cites this paper
• CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy.

  2020cites this paper
• The Role of Steroid Hormone Receptors in Urothelial Tumorigenesis

  2020influential citation
• Novel insights into the function of CD24: A driving force in cancer

  2020cites this paper
• The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma

  2020cites this paper
• Possible role of 5-alpha reductase inhibitors in non-invasive bladder urothelial neoplasm: multicentre study.

  2019cites this paper
• Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy

  2019cites this paper
• The long non-coding RNA LINC00460 predicts the prognosis and promotes the proliferation and migration of cells in bladder urothelial carcinoma

  2019cites this paper
• Androgen Suppression Therapy Is Associated with Lower Recurrence of Non-muscle-invasive Bladder Cancer.

  2019cites this paper
• Hypoxia-Induced Phenotypes that Mediate Tumor Heterogeneity.

  2019cites this paper
• Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis

  2018cites this paper
• Personalized Bladder Cancer Management

  2018cites this paper
• Expression of Androgen Receptor and Cancer Stem Cell Markers ( CD 44 + / CD 24 − and ALDH 1 + ) : Prognostic Implications in Invasive Breast Cancer 1 , 2

  2018cites this paper
• Regulation of breast cancer biomarkers by intrinsic and extrinsic factors

  2018cites this paper
• Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines

  2018cites this paper
• Expression of Androgen Receptor and Cancer Stem Cell Markers (CD44+/CD24− and ALDH1+): Prognostic Implications in Invasive Breast Cancer12

  2018cites this paper
• SOX2‐mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma

  2018cites this paper
• CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer

  2018cites this paper
• Breast Cancer Stem Cells and the Move Toward High-Resolution Stem Cell Systems

  2017cites this paper
• For robust big data analyses: a collection of 150 important pro-metastatic genes

  2017cites this paper
• Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice

  2017cites this paper
• Role of the androgen receptor in urothelial cancer.

  2017cites this paper
• Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.

  2017cites this paper
• Androgen receptor activation: a prospective therapeutic target for bladder cancer?

  2017cites this paper
• Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies

  2017cites this paper
• Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5&agr;‐Reductase Inhibitor

  2017cites this paper
• Androgen Receptor Signaling in Bladder Cancer

  2017cites this paper
• Downregulation of CD24 suppresses bone metastasis of lung cancer

  2017cites this paper
• The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma.

  2016cites this paper
• Understanding the biology of urothelial cancer metastasis

  2016cites this paper
• Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer

  2016cites this paper
• Key signaling pathways in the muscle‐invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment

  2016cites this paper
• Androgen receptor (AR) promotes male bladder cancer cell proliferation and migration via regulating CD24 and VEGF.

  2016cites this paper
• Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence

  2016cites this paper
• Enzalutamide as an androgen receptor inhibitor prevents urothelial tumorigenesis.

  2016cites this paper
• GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.

  2016influential citation
• Enzalutamide inhibits androgen receptor-positive bladder cancer cell growth.

  2016cites this paper
• CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models

  2016cites this paper
• Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice

  2016cites this paper
• Correlation of CD24 expression with histological grading and TNM staging of retinoblastoma

  2016cites this paper
• Targeted therapies in bladder cancer: an overview of in vivo research

  2015cites this paper
• Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer

  2015cites this paper
• The emerging role of the androgen receptor in bladder cancer.

  2015cites this paper
• Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.

  2015cites this paper
• Silencing of CD24 Enhances the PRIMA-1–Induced Restoration of Mutant p53 in Prostate Cancer Cells

  2015cites this paper
• Expression of CD24 in Human Bone Marrow-Derived Mesenchymal Stromal Cells Is Regulated by TGFβ3 and Induces a Myofibroblast-Like Genotype

  2015cites this paper
• Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.

  2015cites this paper
• Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery

  2015cites this paper
• ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression

  2015cites this paper
• Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development

  2015cites this paper
• Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor

  2015cites this paper
• Androgen deprivation therapy prevents bladder cancer recurrence

  2014cites this paper
• Progress made in the use of animal models for the study of high-risk, nonmuscle invasive bladder cancer

  2014cites this paper
• Biomarkers in bladder cancer: translational and clinical implications.

  2014cites this paper
• Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.

  2014cites this paper
• USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.

  2014cites this paper
• Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

  2014cites this paper
• Clinical significance of CD24 as a predictor of bladder cancer recurrence

  2013cites this paper
• Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis

  2013cites this paper
• Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.

  2013cites this paper
• Therapeutics , Targets , and Chemical Biology USP 22 Regulates Oncogenic Signaling Pathways to Drive Lethal Cancer Progression

  2013cites this paper
• Bladder cancer: Androgen-dependent CD24 regulates bladder cancer progression—a new role for antiandrogen therapy?

  2012cites this paper
• Navigating the path of Cancer Immunotherapeutics: Novel Targets and Innovative Development Tools

  year unknowncites this paper